Steven Gannon, Director at Fusion Pharmaceuticals Inc. (FUSN), bought 88,800 shares at $2.03 ($180K) on 2022-08-11, disclosed to the SEC on 2022-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.03 | 44,400 | $90K | 50.0% |
| 2 | $2.03 | 44,400 | $90K | 50.0% |
| Total | $2.03 avg | 88,800 | $180K | 100% |
| Filing → |
| XENE | SELL | 2024-03-08 | $602K | — | Filing → |
| FUSN | BUY | 2021-08-23 | $23K | — | Filing → |
| FUSN | BUY | 2021-08-20 | $26K | — | Filing → |